Clinical trial
An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
NCT03714373 is registered in ClinicalTrials.gov with Soleno Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
- Lead sponsor
- Soleno Therapeutics, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 1, 2018
- Completion date
- August 17, 2023
- Enrollment
- 115 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.